Clinical Trial Update: Efficacy and Safety of Avatrombopag for Treating TCP in HBV-ACLF Patients Receiving ALSS Treatment [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating the efficacy and safety of avatrombopag for thrombocytopenia in patients with HBV-related acute-on-chronic liver failure un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• On Chronic Liver Failure
• Thrombocytopenia

Drugs mentioned

• Avatrombopag (avatrombopag)

Snippet

Sponsor: Third Affiliated Hospital, Sun Yat-Sen University | Conditions: Thrombocytopenia, Hepatitis B, Chronic | Phase 4 | Status: UNKNOWN